Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

Dermata Therapeutics, Inc.

Open Dermata Therapeutics, Inc. profile →

Director at Dermata Therapeutics, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-13

PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-13

Dermata Therapeuti…Dermata Therapeutics, Inc.TENAX THERAPEUTICS…TENAX THERAPEUTICS, INC.Gerald T. Proehl

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Form OwnershipPublic profile sourceSupports Director at Dermata Therapeutics, Inc. (NASDAQ: DRMA), PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (NASDAQ: DRMA), Board membership, Executive title.Open sourceSource 2 · Sec FilingTENX DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 3 · Sec FilingDRMA DEF 14A director slateSupports Board role, Committee assignments.Open sourceSource 4 · Sec FilingDRMA 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:gerald-t-proehl
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of Dermata Therapeutics, Inc.1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 16, 2026
Board membership · Source reportedServes on the board of TENAX THERAPEUTICS, INC.1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
Board role · CorroboratedBoard role: ChairSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Compensation, Corporate Governance and Nominating1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at Dermata Therapeutics, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Founder, President, Chief Executive Officer and Chair1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: PRESIDENT, CHAIRMAN, CEO1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 16, 2026
Executive title · Source reportedExecutive title: President, Chief Executive Officer and Chairman1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedGerald T. Proehl is also linked to Tenax Therapeutics, Inc. as Chairman of the Board.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources5 records
  1. https://www.sec.gov/Archives/edgar/data/1853816/000149315226039048/ownership.xml

    Sec Form Ownership · Tier not stated · Reviewed Sep 12, 2026

    Supports: Director at Dermata Therapeutics, Inc. (NASDAQ: DRMA) · PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (NASDAQ: DRMA) · Board membership · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  3. https://www.sec.gov/Archives/edgar/data/34956/000119312526168580/tennx-20260417.htm

    Sec Proxy · Tier not stated · Reviewed Apr 25, 2026

    Supports: Director at TENAX THERAPEUTICS, INC. (NASDAQ: TENX) · Board membership

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background